(Q52543752)

3 May 2018

title

Bradykinin antagonist decreases early disruption of the blood-spinal cord barrier after spinal cord injury in mice. (English)

1 reference

3 May 2018

2

Kastin AJ

1 reference

3 May 2018

author name string

Pan W

series ordinal

1

1 reference

3 May 2018

Gera L

series ordinal

3

1 reference

3 May 2018

Stewart JM

series ordinal

4

1 reference

3 May 2018

language of work or name

English

0 references

publication date

1 July 2001

1 reference

3 May 2018

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

3 May 2018

volume

307

1 reference

3 May 2018

issue

1

1 reference

3 May 2018

page(s)

25-28

1 reference

3 May 2018

Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901904-8

7 January 2021

Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901904-8

7 January 2021

Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901904-8

7 January 2021

Ultrastructural blood-brain barrier alterations and edema formation in acute spinal cord trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901904-8

7 January 2021

Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901904-8

7 January 2021

Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901904-8

7 January 2021

Neuroprotective signal transduction: relevance to stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901904-8

7 January 2021

Traumatic brain contusions: a clinical role for the kinin antagonist CP-0127.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901904-8

7 January 2021

Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901904-8

7 January 2021

Permeability of the blood-brain and blood-spinal cord barriers to interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901904-8

7 January 2021

Tumor necrosis factor-alpha: a neuromodulator in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901904-8

7 January 2021

Increase in TNFalpha transport after SCI is specific for time, region, and type of lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901904-8

7 January 2021

Tumor necrosis factor facilitates regeneration of injured central nervous system axons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901904-8

7 January 2021

10.1016/S0304-3940(01)01904-8

Identifiers

DOI

1 reference

3 May 2018

1 reference

3 May 2018